Monoterpenoid derivatives for treatment of cancer
CA 2322165 A1 · Owner: Elson, Charles E. · Inventors: Elson, Charles E.; Mo, Huanbiao
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of inhibiting or preventing the growth of tumor cells is disclosed. In one embodiment, this method comprises the step of administering a compound selected from the group consisting of citracetal citral dimethyl acetal, citral diethyl acetal geranyl benzoate, geranyl tiglate, geranyl anthranilate, farnesyl benzoate, farnesyl anthranilate farnesyl tiglate, farnesyl acetate and combinations there of to a human tumor patient wherein , the amount is effective to reduce or inhibit tumor growth by at least 50 %.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 9, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 9, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 9, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.